EBR/HYL (EBR/HYL)

Euronext Brussels: EBR/HYL · EUR

€3.65

+0.00 (0.0%)· Recorded snapshot

Market cap	102.2M
Revenue (ttm)	9.8M
Net income (ttm)	-4.7M
EPS (ttm)	-€0.17
Shares out	28M
Volume	3,101
Beta	0.64

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9.8M
Net income (ttm): -4.7M
EPS (ttm): -€0.17
Market cap: 102.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-17.3

P25 n/aP50 n/aP75 n/a

ROIC-13.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All EBR/HYL indicators

Market & fundamental data

Available fields

190

Groups with data

Currency

EUR

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Belgium
Country code	BE
Earnings date	2027-03-25
Employees	54
Employees change	-1
Employees growth	-1.82%
Enterprise value	EUR 94.9M
Exchange	Euronext Brussels
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2012
Industry	Biotechnology
Is primary listing	Yes
ISIN number	BE0974363955
Last earnings date	2026-09-24
Last refreshed	2026-10-28
Market cap	EUR 102.2M
Next earnings date	2027-03-25
Price	EUR 3.65
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ebr/HYL
Website	https://hyloris.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-4.7%
EV/Sales	9.66x
FCF / EV yield	-8.25%
FCF yield	-7.66%
Industry P/E	28.34x
P/B ratio	4.1x
P/S ratio	10.4x
Price / tangible book value	5.38x
Sector forward P/E	22.59x
Sector P/E	29.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-61.43%
EBITDA margin	-59.48%
Gross margin	94.41%
Operating margin	-61.43%
Pretax margin	-49.52%
Profit margin	-47.36%
Profit per employee	EUR -86,185
Revenue per employee	EUR 181,981
ROA	-11.29%
ROA (5Y)	-12.43%
ROCE	-22.8%
ROE	-17.29%
ROE (5Y)	-23.5%
ROIC	-13.25%
SBC / revenue	7.2%
Tax / revenue	-2.16%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
Gross profit growth	12.98%
Gross profit growth (Q)	53.5%
Gross profit growth 3Y	42.77%
Gross profit growth 5Y	61.18%
Net income growth quarters	2
Net income growth years	2
Revenue growth	16.17%
Revenue growth (Q)	56.54%
Revenue growth (QoQ)	13.63%
Revenue growth 3Y	44.35%
Revenue growth 5Y	60.21%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -84,000
Depreciation and amortization	EUR 192,000
EBIT	EUR -6M
EBITDA	EUR -5.8M
EPS	EUR -0.17
FCF per share	EUR -0.28
Financing cash flow	EUR -312,000
Free cash flow	EUR -7.8M
Free cash flow minus SBC	EUR -8.5M
Gross profit	EUR 9.3M
Income taxes	EUR -212,000
Investing cash flow	EUR -1.5M
Net borrowing	EUR -247,000
Net cash flow	EUR -9.9M
Net income	EUR -4.7M
Operating cash flow minus SBC	EUR -8.5M
Operating income	EUR -6M
Revenue	EUR 9.8M
Stock-based compensation	EUR 708,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	16.77
Book value per share	EUR 0.93
Debt / equity	0.06
Interest coverage	-95.83
Long-term assets	EUR 13.8M
Long-term liabilities	EUR 1.5M
Net cash (debt)	EUR 7.3M
Net cash / market cap	7.12%
Net cash growth	-58.37%
Net debt / equity	-0.29
Piotroski F-Score	2
Property, plant and equipment	EUR 1.6M
Shareholders' equity	EUR 24.9M
Tangible book value	EUR 19M
Tangible book value per share	EUR 0.71
Total assets	EUR 29.8M
Total cash	EUR 8.7M
Total debt	EUR 1.5M
Total liabilities	EUR 4.9M
WACC	7.72%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.29
Current assets	EUR 16M
Current liabilities	EUR 3.3M
Current ratio	4.82
Inventory turnover	6.46
Net working capital	EUR 4.3M
Quick ratio	4.64
Working capital	EUR 12.7M
Working capital turnover	0.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.09%
Shareholder yield	-2.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 4.66
1D price change	0%
1M price change	-17.98%
1M total return	-17.98%
1W price change	-8.75%
1W total return	-8.75%
1Y price change	-34.82%
1Y return CAGR	-34.84%
1Y total return	-34.82%
20-day SMA	EUR 4.01
200-day SMA	EUR 5.22
3M price change	-21%
3M total return	-21%
3Y price change	-70.8%
3Y return CAGR	-33.65%
3Y total return	-70.8%
50-day SMA	EUR 4.22
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 8.40
52-week high date	2026-01-14
52-week low	EUR 3.38
52-week low date	2026-10-12
5Y price change	-75.25%
5Y return CAGR	-24.37%
5Y total return	-75.25%
6M price change	-32.41%
6M total return	-32.41%
All-time high	EUR 19.10
All-time high date	2022-01-06
All-time low	EUR 2.89
All-time low date	2024-08-02
Average true range (ATR)	EUR 0.24
Average volume	8.6K
Beta (1Y)	0.95
Beta (2Y)	0.79
Beta (5Y)	0.64
Change from 52-week high	-56.55%
Change from 52-week low	7.99%
Change from all-time high	-80.89%
Change from all-time low	26.3%
Change from open	2.82%
Day's gap	-2.74%
Dollar volume	EUR 11,319
High price	EUR 3.65
Low price	EUR 3.55
Monthly RSI	32.78
Open price	EUR 3.55
Position in 52-week range	100%
Previous close	EUR 3.65
Price vs 150-day SMA	-21.67%
Price vs 20-day SMA	-8.86%
Price vs 200-day SMA	-30.08%
Price vs 50-day SMA	-13.43%
Relative volume	0.36
RSI	35.6
Sharpe ratio	-0.82
Sharpe ratio (3Y)	-0.25
Sharpe ratio (5Y)	-0.25
Sortino ratio	-1.12
Sortino ratio (3Y)	-0.31
Sortino ratio (5Y)	-0.27
Volume	3.1K
Weekly RSI	35.1
YTD price change	-46.64%
YTD total return	-46.64%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25.9M
Shares change (QoQ)	-6.52%
Shares change (YoY)	2.09%
Shares held by insiders	7.43%
Shares held by institutions	0%
Shares outstanding	28M

Deeper analysis on EBR/HYL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this EBR/HYL report

Is a complete EBR/HYL research report available?

No complete published report is available for ebr/HYL (EBR/HYL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

EBR/HYL (EBR/HYL)

Price

Financial snapshot

Fair-value bridge

Latest news · EBR/HYL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBR/HYL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EBR/HYL

Frequently asked questions